Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TXMD - TherapeuticsMD Inc


IEX Last Trade
1.91
0.030   1.571%

Share volume: 5,267
Last Updated: Fri 30 Aug 2024 07:45:47 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$1.88
0.03
1.60%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
23%
Profitability 23%
Dept financing 24%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
6.50%
1 Month
6.20%
3 Months
-11.50%
6 Months
-20.46%
1 Year
-50.26%
2 Year
-80.94%
Key data
Stock price
$1.91
P/E Ratio 
-3.57
DAY RANGE
N/A - N/A
EPS 
-$0.54
52 WEEK RANGE
$1.43 - $3.86
52 WEEK CHANGE
-$0.50
MARKET CAP 
21.739 M
YIELD 
N/A
SHARES OUTSTANDING 
11.532 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.03
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$17,627
AVERAGE 30 VOLUME 
$17,274
Company detail
CEO: Robert Finizio
Region: US
Website: https://www.therapeuticsmd.com/
Employees: 225
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines

Recent news